6Ozawa K,Yamaoka Y, Kitamura O, et al. Clinical application of cytochrome a (plus a3) assay of mitochondria from liver specimens: an aid in determining metabolic tolerance of liver remnant for hepatic resection. Ann Surg, 1974, 180:868-876.
7Igaki H,Tokuuye K,Takeda T,et al. Sequential evaluation of hepatic functional reserve by ^99mTechnetium galactosyl human serum albumin scintigraphy after proton beam therapy: a report of three cases and a review of the literatures. Acta Oncol, 2006,45 : 1102-1107.
8Kwon AH, Ha-Kawa SK, Uetsuji S, et al. Use of technetium ^99m diethylene-triamine-penta aceticacid galactosyl-humanseru malbumin liver scintigraphy in the evaluation of preperative And postoperative hepatic function alreserve for hepatectomy. Surgery, 1995,117:429-434.
9Kim YK, Nakano H, Yamaguchi M, et al. Prediction of postopera-tivede compensated liver function by technetium-^99m galacto-syl-human serumal bumin liver scintigraphyin patients with hepatocellur carcinoma complicating chronic liver diease.Br J Surg,1997,84:793-796.
10Caban A. Wiaderkiewicz R,Kaminski M, et al. Arterial ketone index in assessing liver function and its detoxicative capability after ischemia-reperfusion injury. Acta Biochim Pol, 2000, 47:1137- 1146.
